Pathogen News and Research

RSS

SARS-CoV-2 spike protein can lead to heart muscle injury through the inflammatory process

Heart damage is common among patients hospitalized with COVID-19, leading many to wonder how the virus affects the heart.

25 Jul 2022

Scientists explore COVID-19-associated pulmonary aspergillosis

Researchers computationally investigated the causes of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA).

25 Jul 2022

LJI study about common cold coronaviruses may offer clues to how immunity can build up against SARS-CoV-2

For a glimpse into the future of SARS-CoV-2 immunity, scientists at La Jolla Institute for Immunology (LJI) are investigating how the immune system builds its defenses against common cold coronaviruses (CCCs).

21 Jul 2022

New AI software can create proteins that may be useful as vaccines, cancer treatments

Scientists have developed artificial intelligence software that can create proteins that may be useful as vaccines, cancer treatments, or even tools for pulling carbon pollution out of the air.

21 Jul 2022

Researchers discover new chromosomal section effective against diseases in oats

Whether you opt for a crunchy granola bar, mushy bowl of oatmeal, or smooth glass of oat milk, it is clear oats are gaining popularity - both with consumers and breeders. Oats provide a naturally gluten-free source of nutrition, with proven health benefits for humans and livestock.

21 Jul 2022

The clinical, epidemiological, and evolutionary consequences of a potential SARS-CoV-2-related bat virus spillover into humans

A team of scientists from France has recently described the epidemiological and clinical consequences of a bat sarbecovirus infection in humanized mice.

20 Jul 2022

Chewing gum containing plant-based antiviral proteins neutralizes SARS-CoV-2 and influenza viruses

A new study has explored the entrapment efficacy of CTB-ACE2 chewing gum against different strains of SARS-CoV-2.

20 Jul 2022

New vaccine shows promise to fight Lassa virus

Researchers at the University of Texas Medical Branch have achieved success with a new vaccine developed to fight Lassa Virus, a pathogen that causes Lassa fever.

19 Jul 2022

CDC experts update on monkeypox in the United States

Scientists working with the CDC provide the latest information about monkeypox in the U.S.

19 Jul 2022

Gut-lung axis: Using commensal bacteria to reinforce mucosal immunity

A recent study discusses the use of commensal bacteria in the gut and/or respiratory tract to deliver viral antigens to the host, thus acting as vaccines

19 Jul 2022

Influence of chr12q24.13 domain on COVID-19 severity

Researchers evaluated the probable impact of the chr12q24.13 domain on the outcomes of laboratory-validated SARS-CoV-2 infection.

19 Jul 2022

Research describes one of the ways the SARS-CoV-2 virus recruits cells to replicate

An article published in the journal Frontiers in Cellular and Infection Microbiology reports a study by researchers at the State University of Campinas (UNICAMP) and the University of São Paulo (USP) in Brazil showing how a human protein interacts with a SARS-CoV-2 protein, and describing one of the ways the virus that causes COVID-19 recruits cells to replicate.

18 Jul 2022

Future SARS-CoV-2 vaccines could hijack commensal bacteria in the gut–lung axis to confer immunity

Researchers screened bacterial mucosal vaccine vectors from 2015 to the present to identify a promising candidate to present SARS-CoV-2 spike protein or its fragments.

18 Jul 2022

The state of antimicrobial resistance in the United States immediately following the 2020 peaks of the COVID-19 pandemic

Researchers assessed the impact of COVID-19 on antimicrobial resistance.

18 Jul 2022

Texas Biomed professor to join $577 million effort for developing antivirals against COVID-19 and other viruses

As the coronavirus waves keep coming and cases are on the rise once again, the National Institutes of Health (NIH) recently launched a $577 million effort to develop antivirals against COVID-19 and other viruses with high pandemic potential.

15 Jul 2022

Chemokine-DNA nanoparticles can induce chronic, dysfunctional immune responses

Small proteins, called chemokines, that direct immune cells toward sites of infection can also form DNA-bound nanoparticles that can induce chronic, dysfunctional immune responses, according to a new study by researchers at Weill Cornell Medicine and Hospital for Special Surgery (HSS).

15 Jul 2022

WHO issues an urgent call to accelerate access to genomics in resource-poor countries

The World Health Organization (WHO) has issued an urgent call to accelerate access to genomics, especially in resource-poor countries, in a report that examines technology gaps and opportunities.

15 Jul 2022

COVID-19 pandemic pushes back years of progress made in fighting antimicrobial resistance

The COVID-19 pandemic pushed back years of progress made in combating antimicrobial resistance (AR) in the United States.

14 Jul 2022

Bacterial species known for causing diarrheal infections may also drive colorectal cancer

Data collected by researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy suggest that Clostridioides difficile, or C. diff, a bacterial species well known for causing serious diarrheal infections, may also drive colorectal cancer.

14 Jul 2022

Bacterial infections cause sperm dysfunction via their outer membrane vesicles

A new study discusses the impact of Escherichia coli (E. coli) infection on sperm parameters.

13 Jul 2022

Pathogen News and Research

SARS-CoV-2 spike protein can lead to heart muscle injury through the inflammatory process

Scientists explore COVID-19-associated pulmonary aspergillosis

LJI study about common cold coronaviruses may offer clues to how immunity can build up against SARS-CoV-2

New AI software can create proteins that may be useful as vaccines, cancer treatments

Researchers discover new chromosomal section effective against diseases in oats

The clinical, epidemiological, and evolutionary consequences of a potential SARS-CoV-2-related bat virus spillover into humans

Chewing gum containing plant-based antiviral proteins neutralizes SARS-CoV-2 and influenza viruses

New vaccine shows promise to fight Lassa virus

CDC experts update on monkeypox in the United States

Gut-lung axis: Using commensal bacteria to reinforce mucosal immunity

Influence of chr12q24.13 domain on COVID-19 severity

Research describes one of the ways the SARS-CoV-2 virus recruits cells to replicate

Future SARS-CoV-2 vaccines could hijack commensal bacteria in the gut–lung axis to confer immunity

The state of antimicrobial resistance in the United States immediately following the 2020 peaks of the COVID-19 pandemic

Texas Biomed professor to join $577 million effort for developing antivirals against COVID-19 and other viruses

Chemokine-DNA nanoparticles can induce chronic, dysfunctional immune responses

WHO issues an urgent call to accelerate access to genomics in resource-poor countries

COVID-19 pandemic pushes back years of progress made in fighting antimicrobial resistance

Bacterial species known for causing diarrheal infections may also drive colorectal cancer

Bacterial infections cause sperm dysfunction via their outer membrane vesicles

Best practices - optimize qPCR processes for pathogen detection eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics